Fig. 1
From: Pharmacological evaluation of newly synthesized organotin IV complex for antiulcer potential
A and B represents 2D and 3D-structures of 2E,2′E) dibutylstannanediyl bis (4-((4-nitrophenyl) amino)-4-oxobut-2-enoate (DTN)
Fig. 1 | BMC Pharmacology and Toxicology